NORTHPOINTE CAPITAL LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 35 filers reported holding CANCER GENETICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHPOINTE CAPITAL LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2014$1,084,000
-64.4%
120,408
-55.4%
0.12%
-60.9%
Q2 2014$3,048,000269,7630.29%
Other shareholders
CANCER GENETICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 22,203$148,0002.90%
Millrace Asset Group, Inc. 187,184$1,250,0001.30%
Sterneck Capital Management, LLC 60,650$405,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$560,0000.15%
Quality Growth Management, Inc. 23,500$157,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$334,0000.05%
DIKER MANAGEMENT LLC 35,015$234,0000.05%
SSI INVESTMENT MANAGEMENT LLC 65,043$434,0000.04%
BANK OF MONTREAL /CAN/ 616,430$4,118,0000.01%
Commonwealth Equity Services, Inc 27,100$181,0000.00%
View complete list of CANCER GENETICS INC shareholders